Read articles from Global

October 02, 2025 by nature.com

Participants aged 18-35, including ENDS users and controls, underwent saliva and subgingival plaque collection. Periodontal screening was conducted using CPITN. Saliva was collected after rinsing with water. Puffing behavior was assessed, and VOC emissions were analyzed. Subgingival plaque samples were collected following HMP protocols. DNA isolation, amplicon sequencing, and taxonomic annotation were performed. Microbiome analysis included diversity assessment and beta diversity using Bray-Curtis distances. Functional profiling was done using Tax4Fun2. Salivary metabolomics were analyzed, and microbiome-metabolome functional connections explored. Network integration analysis using xMWAS was conducted. Statistical analyses were adjusted for demographic factors. The study aimed to understand oral microbiome responses to ENDS use and associated metabolomic changes.

October 02, 2025 by nature.com

Participants aged 18-35, including ENDS users and controls, underwent saliva and subgingival plaque collection. Periodontal screening was conducted using CPITN. Saliva was collected after rinsing with water. Puffing behavior was assessed, and VOC emissions were analyzed. Subgingival plaque samples were collected following HMP protocols. DNA isolation, amplicon sequencing, and taxonomic annotation were performed. Microbiome analysis included diversity assessment and beta diversity using Bray-Curtis distances. Functional profiling was done using Tax4Fun2. Salivary metabolomics were analyzed, and microbiome-metabolome functional connections explored. Network integration analysis using xMWAS was conducted. Statistical analyses were adjusted for demographic factors. The study aimed to understand oral microbiome responses to ENDS use and associated metabolomic changes.

October 01, 2025 by gfn.tv

Public health’s assault on vaping and safer nicotine products isn’t guided by evidence, it’s driven by fear, outrage, and a profound misunderstanding of risk. At GFN 2025 in Warsaw, David Zaruk, the “Risk-Monger,” reveals how emotion overrides science in policymaking. From the misuse of the Precautionary Principle to the denormalization of entire industries, Zaruk argues that activist zeal and WHO dogma have turned nicotine into a moral battleground, sacrificing harm reduction and leaving millions of smokers without safer options.

September 30, 2025 by filtermag.org

The upcoming COP11 in Geneva will address tobacco control policies with potential impacts on global public health. Concerns exist over the exclusion of THR advocates at previous conferences, affecting the discussions on harm reduction products such as vapes. The complex registration process for COP11 has attracted criticism, with fears of limited public participation. Despite resistance from the WHO, advocates aim to emphasize harm reduction benefits at the conference. Prominent countries like New Zealand have supported THR, indicating a hopeful shift in attitudes towards public health strategies. Advocates stress the need for the FCTC treaty to prioritize smoking-related harm and resist external influences for effective tobacco control.

September 30, 2025 by gfn.tv

Explore tobacco harm reduction at GFN through a candid interview with Brazilian consumer advocate Alexandro Lucian, who shares why this global event matters, the misinformation challenges in Brazil, and why education and accurate science are essential for safer nicotine choices. Learn how language barriers, anti‑vaping narratives, and limited local research shape public opinion—and how translating complex evidence into Portuguese helps counter myths.

September 30, 2025 by inews.co.uk

Vaping is often claimed to be 95% safer than smoking, but there are debates on the accuracy of this statistic. Public health messaging on vaping's safety is under scrutiny, with concerns about potential misinformation leading to increased youth vaping. However, research indicates that while vaping is relatively safer, it is not risk-free. The discussion highlights the importance of transparent communication in public health messaging. Contrary to assumptions, youth perceptions on vaping harm have shifted negatively. Additionally, promoting baby-led weaning and debunking myths about excessive water consumption are other topics of interest in recent articles. Moreover, a group of psychologists is focusing on correcting errors in scientific research.

September 29, 2025 by drugtopics.com

Vaping during pregnancy poses risks such as preterm birth, low birth weight, and fetal growth issues. A study suggests complete nicotine cessation for pregnant individuals due to harmful substances in e-cigarettes. Up to 7% of women vape during pregnancy, increasing concerns despite some considering it safer than smoking. Research shows a 40% higher risk of preterm birth, 49% risk of low birth weight, and 32% risk of small-for-gestational-age babies with vaping. The study reviewed data from 9 studies involving 423,680 pregnant women. Advocates stress the need to educate on risks, support quitting, and regulate vaping marketing to protect maternal and fetal health.

September 29, 2025 by regulatorwatch.com

Youth smoking in the United States has collapsed to historic lows, yet public health remains silent. At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with. In this episode of RegWatch, Dr. Chris Junker [...], discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.

September 29, 2025 by regulatorwatch.com

Youth smoking in the United States has collapsed to historic lows, yet public health remains silent. At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with. In this episode of RegWatch, Dr. Chris Junker [...], discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.

September 29, 2025 by regulatorwatch.com

Youth smoking in the United States has collapsed to historic lows, yet public health remains silent. At the same time, adult smokers are moving in record numbers to safer nicotine products, signaling a profound market shift that regulators struggle to keep pace with. In this episode of RegWatch, Dr. Chris Junker [...], discusses the FDA’s slow-moving PMTA process, the collapse of youth smoking, and the importance of scientific transparency in tobacco harm reduction.